• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[对甲状腺激素的抵抗]

[Resistance to thyroid hormone].

作者信息

Takeda K, Hashimoto K

机构信息

Second Department of Internal Medicine, Kochi Medical School.

出版信息

Nihon Rinsho. 1994 Apr;52(4):922-8.

PMID:8196181
Abstract

Resistance to thyroid hormone (RTH), Refetoff's syndrome, is a syndrome of reduced responsiveness of target tissue to thyroid hormone (TH). Inheritance is usually autosomal dominant except in one family, being recessive. Since a point mutation was first discovered in the thyroid hormone receptor (TR) beta gene of a subject with RTH, approximately 93 unrelated families with RTH have been found to have mutations on TR beta gene. Clinically they presented either generalized (GRTH) or dominantly pituitary (PRTH) resistance to TH. In one family, affected consanguineous individuals lacked the entire protein coding region of both hTR beta alleles. In this family with recessively inherited RTH, the obligate heterozygous parents exhibited no clinical and laboratory abnormalities. Thus, manifestation of RTH in heterozygous individuals required the expression of a mutant receptor that interferes with the function of normal allele ("dominant negative effect"). The formation of mutant TR/TRAP (RXR etc.) heterodimer or mutant TR homodimer having the capability to bind the DNA for this dominant negative suppression of mutant TR beta, and the variation of TRE types, receptor isoforms and auxiliary proteins depending on the target tissue may play an important role in the manifestation of TH resistance. This may explain in part the intra- and inter-individual differences in organ resistance in patients with RTH. Studying the errors of nature would contribute to understand the molecular mechanism of TH action.

摘要

甲状腺激素抵抗(RTH),即Refetoff综合征,是一种靶组织对甲状腺激素(TH)反应性降低的综合征。除了一个家族为隐性遗传外,其遗传方式通常为常染色体显性遗传。自从在一名患有RTH的患者的甲状腺激素受体(TR)β基因中首次发现点突变以来,大约93个与RTH无关的家族被发现其TRβ基因存在突变。临床上,他们表现为全身性(GRTH)或主要为垂体性(PRTH)甲状腺激素抵抗。在一个家族中,受影响的近亲个体缺乏两个hTRβ等位基因的整个蛋白质编码区域。在这个隐性遗传RTH的家族中,必然的杂合子父母没有表现出临床和实验室异常。因此,杂合子个体中RTH的表现需要表达一种干扰正常等位基因功能的突变受体(“显性负效应”)。具有这种显性负性抑制突变TRβ能力的突变TR/TRAP(RXR等)异二聚体或突变TR同二聚体的形成,以及取决于靶组织的TRE类型、受体亚型和辅助蛋白的变化,可能在TH抵抗的表现中起重要作用。这可能部分解释了RTH患者器官抵抗的个体内和个体间差异。研究自然错误将有助于理解TH作用的分子机制。

相似文献

1
[Resistance to thyroid hormone].[对甲状腺激素的抵抗]
Nihon Rinsho. 1994 Apr;52(4):922-8.
2
[Diagnosis of thyroid hormone resistance by molecular biology].[甲状腺激素抵抗的分子生物学诊断]
Nihon Rinsho. 1994 Apr;52(4):929-34.
3
Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.五个新的甲状腺激素抵抗家族,并非由甲状腺激素受体β基因突变所致。
J Clin Endocrinol Metab. 1999 Nov;84(11):3919-28. doi: 10.1210/jcem.84.11.6080.
4
Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.甲状腺激素受体突变体之间的异构体可变作用为深入了解垂体对甲状腺激素的抵抗提供了线索。
Mol Endocrinol. 1997 Jan;11(1):16-26. doi: 10.1210/mend.11.1.9867.
5
Genetic analysis of thyroid hormone receptors in development and disease.甲状腺激素受体在发育和疾病中的遗传分析。
Recent Prog Horm Res. 1996;51:1-22.
6
Screening of nineteen unrelated families with generalized resistance to thyroid hormone for known point mutations in the thyroid hormone receptor beta gene and the detection of a new mutation.对19个甲状腺激素全身性抵抗的无关家族进行甲状腺激素受体β基因已知点突变的筛查及一个新突变的检测。
J Clin Invest. 1991 Feb;87(2):496-502. doi: 10.1172/JCI115023.
7
Resistance to thyroid hormone--an uncommon cause of thyroxine excess and inappropriate TSH secretion.甲状腺激素抵抗——甲状腺素过量和促甲状腺激素分泌异常的罕见原因。
Acta Med Austriaca. 1994;21(2):56-60.
8
Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor.对甲状腺激素抵抗的显性遗传与甲状腺激素受体α或β基因缺陷无关,可能是由于辅助因子缺陷所致。
J Clin Endocrinol Metab. 1996 Dec;81(12):4196-203. doi: 10.1210/jcem.81.12.8954015.
9
Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome.甲状腺激素抵抗综合征中二十种不同突变型甲状腺激素β受体的转录、二聚化及显性负性特性谱
Mol Endocrinol. 1994 Sep;8(9):1262-77. doi: 10.1210/mend.8.9.7838159.
10
[Pathogenesis of disorder due to thyroid hormone receptor mutation].[甲状腺激素受体突变所致疾病的发病机制]
Rinsho Byori. 1998 Oct;46(10):1017-22.